Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISME
2014-001462-99Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2017
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of allogeneic bone marrow-derived mesenchymal stromal cells (ICSCYL) in gastrointestinal conditions, sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2017; status: terminated.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells (ICSCYL)
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on 2014-001462-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001462-99.